JP2020041965A - Device and method for testing for protozoal infections - Google Patents
Device and method for testing for protozoal infections Download PDFInfo
- Publication number
- JP2020041965A JP2020041965A JP2018171213A JP2018171213A JP2020041965A JP 2020041965 A JP2020041965 A JP 2020041965A JP 2018171213 A JP2018171213 A JP 2018171213A JP 2018171213 A JP2018171213 A JP 2018171213A JP 2020041965 A JP2020041965 A JP 2020041965A
- Authority
- JP
- Japan
- Prior art keywords
- infection
- protozoan
- blood cells
- test
- change
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
【課題】原虫感染症を簡単・高精度にしかも安価に検査できるとともに、特に感染初期でも迅速に検査できる検査装置および検査方法を提供する。【解決手段】寄生性原虫が感染した被検全血および/または赤血球および/または白血球および/または血漿の物理的特性の変化を電気的特性の変化として高感度で検知することにより、原虫感染症を高精度かつ迅速に検査するものである。電気的特性として、インピーダンスを測定することが望ましい。【選択図】図2PROBLEM TO BE SOLVED: To provide an inspection device and an inspection method capable of inspecting a protozoan infection easily, highly accurately and inexpensively, and particularly quickly in the early stage of infection. A protozoan infection by detecting changes in the physical properties of whole blood and / or erythrocytes and / or leukocytes and / or plasma infected with a parasitic protozoan with high sensitivity as changes in electrical properties. Is to be inspected with high accuracy and speed. As an electrical characteristic, it is desirable to measure impedance. [Selection diagram] Fig. 2
Description
本発明は、原虫感染症の検査装置および検査方法に関するものである。 The present invention relates to a protozoan infection inspection apparatus and an inspection method.
マラリアはマラリア原虫が赤血球に、トキソプラズマ症はトキソプラズマが白血球を含む有核細胞に寄生することで引き起こされ、トリパノソーマ症はトリパノソーマが血流中で増殖することによって引き起こされる感染症である。 Malaria is caused by malaria parasites in erythrocytes, toxoplasmosis is caused by parasitism of toxoplasma in nucleated cells including leukocytes, and trypanosomiasis is an infection caused by trypanosomes growing in the bloodstream.
また、ピロプラズマ症はバベシアが動物の赤血球に、もしくは、タイレリアが動物の赤血球および/または白血球に寄生することによって引き起こされる感染症である。 Piroplasmosis is an infection caused by Babesia parasitizing an animal's erythrocytes or Tyleria on an animal's erythrocytes and / or leukocytes.
また、ロイコチトゾーン症はロイコチトゾーンが主に鳥類の赤血球に寄生することによって引き起こされる感染症である。 Leukocytosonosis is an infection caused by leukocytozone mainly infesting avian red blood cells.
2016年時点で、全世界では年間2.16億人がマラリアに感染し、うち44.5万人が死亡している(非特許文献1)。 As of 2016, 216 million people worldwide are infected with malaria annually, of which 44.5 million die (Non-Patent Document 1).
また、世界人口の1/3がトキソプラズマに感染しているといわれており、健康な成人の場合には感染しても無徴候に留まるか、軽い風邪のような症状が出る程度である(日和見感染症)。しかし胎児・幼児や臓器移植やエイズの患者など、免疫抑制状態にある場合には重症化して死に至ることもある(非特許文献2)。 It is said that one-third of the world's population is infected with Toxoplasma. In healthy adults, infection remains asymptomatic or causes mild cold-like symptoms (opportunistic). Infection). However, when the patient is in an immunosuppressed state, such as a fetus / infant, an organ transplant, or a patient with AIDS, the disease may become severe and lead to death (Non-Patent Document 2).
また、トリパノソーマ症は病状が進行すると髄膜脳炎を起こし、最終的には昏睡状態に陥って死に至ることから「アフリカ睡眠病」とも呼ばれており、感染リスクを抱える人々はサハラ以南のアフリカ36カ国で6000から7000万人と推定されている(非特許文献3)。 Trypanosomiasis is also called `` African sleeping sickness '' because as the disease progresses, it causes meningoencephalitis, eventually falling into a coma and dying, and people at risk of infection are located in sub-Saharan Africa. It is estimated that the number is between 60 and 70 million in 36 countries (Non-Patent Document 3).
また、ピロプラズマ症は、トリパノソーマ症とともに家畜等に大きな被害をもたらしている(非特許文献4)。 Piroplasmosis, along with trypanosomiasis, has caused great damage to livestock and the like (Non-Patent Document 4).
ロイコチトゾーン症は、養鶏業に被害をもたらす感染症である(非特許文献5)。 Leukocytosonosis is an infectious disease that damages the poultry industry (Non-Patent Document 5).
例えば、従来から広く用いられているマラリアの検査方法としては血液塗沫検査法があり、血液をスライドガラスに塗りつけギムザ染色を行い顕微鏡観察している。 For example, a blood smear test method has been widely used as a test method for malaria in the past, and blood is applied to a slide glass and subjected to Giemsa staining, followed by microscopic observation.
また、蛍光染色により蛍光透過光の強度を測定する等、顕微鏡観察に相当する工程を機械的に行う方法も提案されている(特許文献1)。 Further, a method of mechanically performing a step corresponding to microscopic observation, such as measuring the intensity of transmitted fluorescence light by fluorescence staining, has been proposed (Patent Document 1).
また近年、血液中のマラリア原虫が持つ特異的な物質を感知し、感染したことを試験紙の上に赤い線として現す簡易検査キットが用いられるようになっている(非特許文献6)。 In recent years, a simple test kit that detects a specific substance of malaria parasite in blood and shows that the infection has occurred as a red line on a test paper has been used (Non-Patent Document 6).
他の原虫感染症については、従来からの血液塗沫検査法が用いられており、トリパノソーマ症においては、感度を高めるために血液を遠心分離して白血球部分を観察する等の検査法が取られている。 For other protozoal infections, the conventional blood smear test method is used.In trypanosomiasis, test methods such as centrifugation of blood and observation of leukocyte parts are used to increase sensitivity. ing.
さらに近年、マラリア感染の初期段階の新たな検査法として、感染した赤血球中でマラリア原虫がヘモグロビンから産生する代謝副産物であるヘモゾインの磁気特性変化を検出する技術が発表されている(非特許文献7)。 Furthermore, in recent years, as a new test method in the early stage of malaria infection, a technology for detecting a change in magnetic properties of hemozoin, which is a metabolic byproduct produced by malaria parasite from hemoglobin in infected red blood cells, has been published (Non-Patent Document 7). ).
背景技術で示した検査方法には、以下のように課題がある。
(1)血液塗沫検査法は、顕微鏡観察の前に標本の作成、固定、染色の各工程を要し、手間がかかるとともに感染初期の低原虫濃度の場合は検出が困難である。
(2)顕微鏡観察に相当する工程を機械的に行う方法も提案されているが、装置が極めて高価であり、発展途上国内の多数の感染症発生現地・現場にこのような装置を導入することは現実的ではない。
(3)簡易検査キットを用いた検査方法は、上述の血液塗沫検査法より感度・精度が悪い。また、検査キットを温度が高いところに保管すると精度がさらに悪化する。さらに、アフリカ等の感染地帯ではマラリア以外の感染症、例えば後述するトリパノソーマ症と重複感染している場合もあるが、マラリア用検査キットではマラリアしか検査できないため、感染症の特定には複数の検査を行うこととなり、結果として採血量が増えて浸潤性が高まるとともに時間もかかる。このため、現地・現場での迅速かつ正確な診断法としては十分ではない。
(4)磁気特性変化を検出する技術では、ヘモゾイン等代謝副産物を産生しない原虫感染症を検知できず、また、磁気特性変化の検出装置は高価格になるとともに取り扱いが難しいという問題もある。
The inspection method described in the background art has the following problems.
(1) The blood smear test method requires each step of preparation, fixation, and staining before microscopic observation, which is troublesome and difficult to detect in the case of low protozoan concentration in the early stage of infection.
(2) Although a method of mechanically performing a process corresponding to microscopic observation has been proposed, the device is extremely expensive, and such a device must be introduced to many infectious disease sites and sites in developing countries. Is not realistic.
(3) The test method using the simple test kit has lower sensitivity and accuracy than the blood smear test method described above. Further, if the test kit is stored in a place where the temperature is high, the accuracy is further deteriorated. Furthermore, in infected areas such as Africa, infections other than malaria, such as trypanosomiasis described later, may be co-infected, but since a malaria test kit can test only malaria, multiple tests are needed to identify infectious diseases. As a result, the amount of blood collected increases, the invasiveness increases, and it takes time. For this reason, it is not enough as a quick and accurate diagnostic method on site or on site.
(4) The technique of detecting a change in magnetic properties cannot detect a protozoan infection that does not produce metabolic by-products such as hemozoin, and the magnetic property change detection device is expensive and difficult to handle.
本発明は、上記課題に鑑みてなされたものであり、原虫感染症を簡単・高精度にしかも安価に検査できるとともに、1回の採血および検査により重複感染を検査でき、代謝副産物を産生しない原虫感染症も検査できる検査装置および検査方法を提供することを目的とする。 SUMMARY OF THE INVENTION The present invention has been made in view of the above-mentioned problems, and a protozoan that can easily and accurately test for protozoal infectious diseases at a low cost, and that can detect double infection by a single blood sampling and test and does not produce metabolic by-products It is an object of the present invention to provide an inspection device and an inspection method capable of inspecting an infectious disease.
また、特に感染初期でも高感度かつ高精度かつ迅速に検査する方法が見当たらないことに鑑みてなされたものであり、原虫感染による被検全血および/または赤血球および/または白血球および/または血漿の物理的特性変化を電気的特性変化として高感度で検知するという全く新規な原虫感染症の検査装置および検査方法を提供することを目的とする。 In addition, it has been made in view of the fact that there is no method for performing high-sensitivity, high-precision, and rapid testing, especially in the early stages of infection, and it has been proposed that the whole blood and / or red blood cells and / or white blood cells and / or plasma due to protozoal infection be detected. It is an object of the present invention to provide a completely novel protozoan infection inspection apparatus and method for detecting a change in physical characteristics as a change in electrical characteristics with high sensitivity.
本発明の一つの観点によれば、上記課題を解決するために、本発明は、寄生性原虫が感染した被検全血および/または赤血球および/または白血球および/または血漿の物理的特性の変化を電気的特性の変化として検知する原虫感染症の検査装置に関する。 According to one aspect of the present invention, in order to solve the above-mentioned problems, the present invention provides a method for altering the physical properties of a test whole blood and / or erythrocyte and / or leukocyte and / or plasma infected with a parasitic protozoan. The present invention relates to an apparatus for detecting protozoal infections, which detects a change in electrical characteristics.
さらに、本発明は、電気的特性として、電極間に所定の周波数の交流電圧を印加して被検全血または赤血球または白血球または血漿のインピーダンスを測定する原虫感染症の検査装置に関する。 Further, the present invention relates to a protozoan infection testing apparatus for measuring the impedance of whole blood, red blood cells, white blood cells, or plasma by applying an AC voltage having a predetermined frequency between electrodes as an electrical characteristic.
さらに、本発明は、印加される交流電圧の周波数を順次切り替えながらインピーダンスを測定する原虫感染症の検査装置に関する。 Further, the present invention relates to a protozoan infection inspection apparatus that measures impedance while sequentially switching the frequency of an applied AC voltage.
さらに、本発明は、周波数を0.1MHzから300MHzの範囲で順次切り替える原虫感染症の検査装置に関する。 Further, the present invention relates to a protozoan infection inspection apparatus that sequentially switches the frequency in a range of 0.1 MHz to 300 MHz.
さらに、本発明は、印加される交流電圧の周波数を順次切り替えながらインピーダンスを測定し、1回の採血および検査により重複感染症を検査する原虫感染症の検査装置に関する。 Furthermore, the present invention relates to a protozoan infection testing apparatus that measures impedance while sequentially switching the frequency of an applied AC voltage, and tests for double infection by one blood collection and test.
さらに、本発明は、哺乳類において、赤血球中のマラリア原虫および/またはバベシア、赤血球および/または白血球中のタイレリア、白血球中のトキソプラズマ、全血中のトリパノソーマを検知する原虫感染症の検査装置に関する。 Furthermore, the present invention relates to a protozoan infection testing apparatus that detects malaria parasite and / or babesia in erythrocytes, tyrelia in erythrocytes and / or leukocytes, toxoplasma in leukocytes, and trypanosomes in whole blood in mammals.
さらに、本発明は、鳥類において、赤血球中のマラリア原虫および/またはバベシアおよび/またはロイコチトゾーンを検知する原虫感染症の検査装置に関する。 Furthermore, the present invention relates to a protozoan infection testing apparatus for detecting malaria parasite and / or babesia and / or leukotit zone in erythrocytes in birds.
また、本発明の他の観点によれば、上記課題を解決するために、本発明は、寄生性原虫が感染した被検全血および/または赤血球および/または白血球および/または血漿の物理的特性の変化を電気的特性の変化として検知する原虫感染症の検査方法に関する。 According to another aspect of the present invention, in order to solve the above-mentioned problems, the present invention provides a physical property of a test whole blood and / or erythrocyte and / or leukocyte and / or plasma infected with a parasitic protozoan. The present invention relates to a method for detecting protozoal infections, which detects a change in the electrical characteristics as a change in electrical characteristics.
本発明によれば、原虫感染症を簡単・高精度にしかも安価に検査できるとともに、1回の採血および検査により重複感染を検査でき、代謝副産物を産生しない原虫感染症も検査できる検査装置および検査方法を提供することができる。 ADVANTAGE OF THE INVENTION According to this invention, the test apparatus and test which can test a protozoan infection easily and highly accurately and at low cost, can test for superinfection by one blood collection and test, and can also test protozoal infection which does not produce metabolic by-products A method can be provided.
また、特に感染初期でも高感度かつ高精度かつ迅速に検査する方法が見当たらないことに鑑みてなされたものであり、原虫感染による被検全血および/または赤血球および/または白血球および/または血漿の物理的特性変化を電気的特性変化として高感度で検知するという全く新規な原虫感染症の検査装置および検査方法を提供することができる。 In addition, it has been made in view of the fact that there is no method for performing high-sensitivity, high-precision, and rapid testing, especially in the early stages of infection, and it has been proposed that the whole blood and / or red blood cells and / or white blood cells and / or plasma due to protozoal infection be detected. It is possible to provide a completely novel protozoan infectious disease inspection apparatus and method for detecting a change in physical characteristics as a change in electrical characteristics with high sensitivity.
以下、本発明の実施形態例及び実施例を説明するが、本発明の実施形態は以下に説明する実施形態例及び実施例に限定されない。 Hereinafter, embodiments and examples of the present invention will be described, but embodiments of the present invention are not limited to the embodiments and examples described below.
寄生性原虫に感染すると、被検全血、赤血球、白血球または血漿の物理的特性が変化する。 Infection with a parasitic protozoa changes the physical properties of the test whole blood, red blood cells, white blood cells or plasma.
例えば、マラリア原虫のライフサイクルにおいて原虫に感染したハマダラカが吸血する際に唾液腺感染型虫体である「スポロゾイト」が宿主の体内に注入される。スポロゾイトは数分で肝臓に達し、肝細胞に侵入する。数週間で数万の「メロゾイト」に分裂し、血液中に放出される。メロゾイトは、ただちに赤血球に侵入し、輪状体、栄養体、分裂体などを経て「メロゾイト」を形成する。新しいメロゾイトは、感染した赤血球を破壊し、次の赤血球に感染し、増殖する。このサイクルがくり返され、発熱や貧血が起こる。メロゾイトの一部は雄雌の生殖母体(ガメトサイト)に分化し、これが吸血により蚊の体内に入ると、蚊の中腸内で雌雄の生殖体に成熟した後、接合する。接合体は運動性のオーキネトとなり、中腸基底膜でオーシストに分化する。オーシスト内でつくられた数千の「スポロゾイト」は唾液腺に移行し、感染型の「成熟スポロゾイト」になる。以上のサイクルが知られており、赤血球の物理的特性に変化が生じる。 For example, during the life cycle of a malaria parasite, sporozoites, which are salivary gland-infected parasites, are injected into the body of a host when an anopheles infected with the parasite sucks blood. Sporozoites reach the liver in minutes and invade hepatocytes. In a few weeks, it breaks down into tens of thousands of "merozoites" and is released into the blood. Merozoites immediately invade erythrocytes and form "merozoites" through the ring, vegetative bodies, and meiosis. The new merozoites destroy infected red blood cells, infect the next red blood cells and multiply. This cycle is repeated, resulting in fever and anemia. Some of the merozoites differentiate into male and female reproductive mothers (gametocytes), and when they enter the mosquito by blood feeding, they mature into male and female reproductive bodies in the mosquito's midgut and then join. The zygotes become motile okineto and differentiate into oocysts in the midgut basement membrane. Thousands of "sporozoites" created within the oocyst migrate to the salivary glands and become infectious "mature sporozoites". The above cycle is known, and changes occur in the physical properties of red blood cells.
この物理的特性の変化が、電気的特性の変化として検知できることを見出した。 It has been found that this change in physical properties can be detected as a change in electrical properties.
また、上記において、マラリアはマラリア原虫が赤血球に寄生することで引き起こされる点を説明したが、原虫感染症の種類に応じて感染形態がことなる点が知られている。例えば、トキソプラズマ症はトキソプラズマが白血球を含む有核細胞に寄生することで引き起こされ、トリパノソーマ症はトリパノソーマが血流中で増殖することによって引き起こされ、ピロプラズマ症はバベシアが動物の赤血球に、もしくは、タイレリアが動物の赤血球および/または白血球に寄生することによって引き起こされ、ロイコチトゾーン症はロイコチトゾーンが主に鳥類の赤血球に寄生することによって引き起こされる感染症である。 In the above description, malaria is caused by parasitism of malaria parasite in erythrocytes. However, it is known that the form of infection varies depending on the type of protozoal infection. For example, toxoplasmosis is caused by toxoplasmosis parasitizing nucleated cells, including leukocytes, trypanosomiasis is caused by the proliferation of trypanosomes in the bloodstream, and pyroplasmosis is caused by Babesia in animal red blood cells, or Theileria is caused by the parasitism of red and / or white blood cells in animals, and leukocytosonosis is an infection caused by the parasitism of leukocytozone mainly in avian red blood cells.
したがって、寄生性原虫が感染した被検全血および/または赤血球および/または白血球および/または血漿の物理的特性の変化を電気的特性の変化として検知できるが、検知する電気的特性の変化は、必ずしも原虫そのものの存在による被検全血および/または赤血球および/または白血球および/または血漿の変化である必要はなく、マラリアにおけるヘモゾインのように、代謝副産物によりもたらされる電気的特性の変化からも検知できる。 Therefore, a change in the physical properties of the test whole blood and / or red blood cells and / or white blood cells and / or plasma infected with the parasitic protozoan can be detected as a change in the electrical properties. Not necessarily a change in test whole blood and / or red blood cells and / or white blood cells and / or plasma due to the presence of the protozoan itself, but also a change in electrical properties caused by metabolic by-products, such as hemozoin in malaria it can.
(検体の作製)
マラリア原虫感染マウスの血液をin vitro培養することによって原虫発育ステージを分裂期に同期化し、検体作製用マウスの尾静脈から分裂期マラリア原虫を感染させ、3から6時間後に心臓穿刺により感染血液を採集して1.4%のヘパリンを加え、95%以上の感染赤血球中の原虫が感染初期のリングステージであることを確認した。
(Preparation of specimen)
In vitro culture of malaria parasite-infected mice synchronizes the protozoan developmental stage with the mitotic phase by in vitro cultivation, infects the mitotic malaria parasite through the tail vein of the specimen preparation mouse, and 3 to 6 hours later, the infected blood is collected by cardiac puncture. After collection, 1.4% heparin was added, and it was confirmed that 95% or more of the protozoa in the infected erythrocytes were in the ring stage in the early stage of infection.
健常マウスの血漿を添加することでヘマトクリット値を40%に調整し、非感染赤血球を用いた希釈によって感染赤血球/全赤血球の割合が0.5%、0.1%、0.01%の検体を作製した。 The hematocrit value was adjusted to 40% by adding plasma from healthy mice, and the ratio of infected erythrocytes / total erythrocytes was 0.5%, 0.1%, and 0.01% by dilution with uninfected erythrocytes. Was prepared.
(電気的特性の測定)
図1の電極付き小容器に感染赤血球濃度を調整した検体約500マイクロリットルを注入し、周波数を0.1MHzから300MHzまで変化させながら健常(非感染)マウス血液ならびに0.5%、0.1%、0.01%の検体のレジスタンスおよびリアクタンスを各検体につき20秒程度で測定した。
(Measurement of electrical characteristics)
Approximately 500 microliters of a sample whose infected erythrocyte concentration was adjusted was injected into the small container with electrodes shown in FIG. 1, and while changing the frequency from 0.1 MHz to 300 MHz, healthy (uninfected) mouse blood and 0.5%, 0.1% % And 0.01% of the sample were measured for resistance and reactance in about 20 seconds.
図2に非感染血液、感染初期のリングステージ赤血球濃度が0.5%、0.1%、0.01%のレジスタンスおよびリアクタンスの周波数依存性をプロットした結果を示す。 FIG. 2 shows the results of plotting the frequency dependence of the resistance and reactance of uninfected blood and ring stage red blood cell concentrations of 0.5%, 0.1% and 0.01% at the initial stage of infection.
非感染血液と比較して、感染初期のリングステージ赤血球は、レジスタンスおよびリアクタンスが変化することを確認した。 Compared with uninfected blood, ring stage erythrocytes at the early stage of infection were found to have altered resistance and reactance.
また、赤血球感染率に応じて、レジスタンスおよびリアクタンスが変化することも確認した。 It was also confirmed that the resistance and the reactance changed according to the erythrocyte infection rate.
本発明による検査装置および検査方法により、マラリア感染初期リングステージの赤血球数10000分の1(図2の赤血球感染率0.01%)でも、レジスタンスおよびリアクタンス特性から高感度でかつ短時間でマラリア感染を検知できることが明らかになった。 According to the test apparatus and test method of the present invention, even if the number of red blood cells in the initial ring stage of malaria infection is 1 / 10,000 (red blood cell infection rate of 0.01% in FIG. 2), malaria infection can be performed in a short time with high sensitivity based on resistance and reactance characteristics. It has been found that can be detected.
また、レジスタンスおよびリアクタンス特性から、感染率も推定できることが明らかになった。 In addition, it became clear that the infection rate could be estimated from the resistance and reactance characteristics.
なお、本発明による原虫感染症の検査に供する検体は、測定に数十秒程度と時間を要しないため採血した全血そのままでも良いが、ヘパリン等耐凝固剤の添加や成分分離のためにクエン酸等を加えて遠心分離する等、特に血液の処理方法について制限はないが、例えば、遠心分離で成分分離をすることで、赤血球、白血球、血漿等、特定の成分の電気的特性の変化を測定できるので、より高精度に原虫感染症を検知できる。 The sample to be used for the protozoan infection test according to the present invention does not require a time period of about several tens of seconds for measurement, and may be the whole blood as it is, but may be used for the addition of anticoagulant such as heparin or separation of components. There is no particular limitation on the method of treating blood, such as centrifugation by adding an acid, etc., for example, by separating components by centrifugation, changes in the electrical characteristics of specific components such as red blood cells, white blood cells, plasma, etc. Since it can be measured, protozoal infections can be detected with higher accuracy.
また、原虫感染症の種類に応じて、電気的特性の変化が異なることは明らかである。したがって、1回の採血および検査により測定した電気的特性の変化から各種の原虫感染症の検知が可能であり、重複感染症も検査することができる。 In addition, it is clear that changes in electrical characteristics vary depending on the type of protozoan infection. Therefore, various protozoal infections can be detected from a change in electrical characteristics measured by one blood sampling and test, and a double infection can also be tested.
また、電気的特性として、インピーダンス(レジスタンスおよびリアクタンス)を測定したが、他の電気的特性であるインダクタンス、キャパシタンスなどでもよく、原虫感染症の検査が可能な範囲ならば、如何なる電気的特性でもよい。 In addition, impedance (resistance and reactance) was measured as an electrical property, but other electrical properties such as inductance and capacitance may be used, and any electrical property may be used as long as a test for protozoal infection can be performed. .
本発明は、原虫感染症の検査装置および検査方法として産業上利用可能である。 INDUSTRIAL APPLICABILITY The present invention is industrially applicable as a protozoan infection inspection apparatus and an inspection method.
Claims (8)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018171213A JP7094520B2 (en) | 2018-09-13 | 2018-09-13 | Protozoan infection testing equipment and methods |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018171213A JP7094520B2 (en) | 2018-09-13 | 2018-09-13 | Protozoan infection testing equipment and methods |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020041965A true JP2020041965A (en) | 2020-03-19 |
| JP7094520B2 JP7094520B2 (en) | 2022-07-04 |
Family
ID=69798092
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018171213A Active JP7094520B2 (en) | 2018-09-13 | 2018-09-13 | Protozoan infection testing equipment and methods |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP7094520B2 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111781248A (en) * | 2020-07-15 | 2020-10-16 | 浙江师范大学 | A malaria detection device |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007525674A (en) * | 2004-02-27 | 2007-09-06 | ベックマン コールター,インコーポレイティド | How to detect malaria parasites and other parasitic infections |
| JP2008076143A (en) * | 2006-09-20 | 2008-04-03 | Citizen Holdings Co Ltd | Instrument for measuring hemoglobin concentration |
| JP2012052944A (en) * | 2010-09-02 | 2012-03-15 | Nihon Univ | Erythrocyte monitor and erythrocyte monitoring method |
| US20130183243A1 (en) * | 2010-07-12 | 2013-07-18 | Arizona State University | Methods and Device for Tuning Multiplexed Markers for Disease Assay |
| JP2015508506A (en) * | 2012-01-27 | 2015-03-19 | ユニバーシティ オブ テネシー リサーチ ファウンデーション | Method and apparatus for biomarker detection by AC electrokinetics |
| JP2017071648A (en) * | 2010-12-16 | 2017-04-13 | バクスアルタ ゲーエムベーハー | Real time monitoring and control of protein production process using impedance spectroscopy |
-
2018
- 2018-09-13 JP JP2018171213A patent/JP7094520B2/en active Active
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007525674A (en) * | 2004-02-27 | 2007-09-06 | ベックマン コールター,インコーポレイティド | How to detect malaria parasites and other parasitic infections |
| JP2008076143A (en) * | 2006-09-20 | 2008-04-03 | Citizen Holdings Co Ltd | Instrument for measuring hemoglobin concentration |
| US20130183243A1 (en) * | 2010-07-12 | 2013-07-18 | Arizona State University | Methods and Device for Tuning Multiplexed Markers for Disease Assay |
| JP2012052944A (en) * | 2010-09-02 | 2012-03-15 | Nihon Univ | Erythrocyte monitor and erythrocyte monitoring method |
| JP2017071648A (en) * | 2010-12-16 | 2017-04-13 | バクスアルタ ゲーエムベーハー | Real time monitoring and control of protein production process using impedance spectroscopy |
| JP2015508506A (en) * | 2012-01-27 | 2015-03-19 | ユニバーシティ オブ テネシー リサーチ ファウンデーション | Method and apparatus for biomarker detection by AC electrokinetics |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111781248A (en) * | 2020-07-15 | 2020-10-16 | 浙江师范大学 | A malaria detection device |
Also Published As
| Publication number | Publication date |
|---|---|
| JP7094520B2 (en) | 2022-07-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Spielman et al. | Malaria diagnosis by direct observation of centrifuged samples of blood | |
| Rebelo et al. | A novel flow cytometric hemozoin detection assay for real-time sensitivity testing of Plasmodium falciparum | |
| Barkan et al. | Optimisation of flow cytometric measurement of parasitaemia in plasmodium-infected mice | |
| Janse et al. | Flow cytometry in malaria detection | |
| Esteban-Redondo et al. | Detection of Toxoplasma gondii in tissues of sheep orally challenged with different doses of oocysts | |
| Schallig et al. | Development of a fast agglutination screening test (FAST) for the detection of anti-Leishmania antibodies in dogs | |
| Cursino‐Santos et al. | A novel flow cytometric application discriminates among the effects of chemical inhibitors on various phases of Babesia divergens intraerythrocytic cycle | |
| Xie et al. | Development and validation of flow cytometric measurement for parasitaemia using autofluorescence and YOYO-1 in rodent malaria | |
| JP7094520B2 (en) | Protozoan infection testing equipment and methods | |
| Brasil et al. | Plasmodium simium causing human malaria: A zoonosis with outbreak potential in the Rio de Janeiro Brazilian Atlantic forest | |
| Sunita et al. | Specific antibody detection in serum, urine and saliva samples for the diagnosis of cystic echinococcosis | |
| Liu et al. | A more appropriate white blood cell count for estimating malaria parasite density in Plasmodium vivax patients in northeastern Myanmar | |
| Rebelo et al. | Light depolarization measurements in malaria: A new job for an old friend | |
| Noedl et al. | Malaria drug-susceptibility testing. HRP2-based assays: current data, future perspectives. | |
| Saghrouni et al. | Asymptomatic carriage of Leishmania in family members of patients with visceral leishmaniasis in Central Tunisia | |
| Li et al. | Identification and assessment of Plasmodium berghei merozoites and cell cycle by flow cytometry | |
| JP2018021900A (en) | Blood analyzer and blood analysis method | |
| Shaher Banu et al. | An analysis of the attitude of Patients towards Laboratory Services for Malaria Disease in Hyderabad India | |
| de Lacerda et al. | In Vitro Assay of Plasmodium-Infected Red Blood Cell Killing by Cytotoxic Lymphocytes | |
| Ashankyty | Seroprevalence of Toxoplasma gondii among pregnant women visiting maternity hospital in Hail, KSA | |
| Alsheikly et al. | Prevalence and Serological Diagnosis of Toxoplasmosis in Two regions (Karkh and Rusafa) of Baghdad Province | |
| Shirmohammad et al. | Human visceral leishmaniasis: Seroprevalence survey of asymptomatic adults in an endemic area of Northwestern Iran | |
| Attlmayr et al. | Drug sensitivity of Plasmodium falciparum along the Thai–Myanmar border using the new field-deployable HRP2 in vitro assay | |
| Coêlho et al. | Willis method modification with a view to improving routine coproparasitological diagnosis | |
| US20120264109A1 (en) | Lymphocyte analysis for monitoring the progression of immunodeficiency virus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20210730 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20220304 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20220315 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220506 |
|
| RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20220506 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20220509 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20220614 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20220614 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7094520 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |